prednisone has been researched along with Menopause in 97 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study summarizes the treatment effect of zoledronic acid infusion on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis." | 9.16 | Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. ( Bucci-Rechtweg, C; Devogelaer, JP; Lau, CS; Papanastasiou, P; Reginster, JY; Reid, DM; Roux, C; Saag, K; Sambrook, PN; Su, G, 2012) |
| "Following mastectomy for node-positive breast cancer, 261 postmenopausal women were randomized to observation or adjuvant treatment with cyclophosphamide, fluorouracil, prednisone (CFP) alone or combined with tamoxifen (T)." | 9.06 | Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; Martin, JK; Paulsen, JK; Twito, DI; Votava, HJ; Wieand, HS; Wold, LE, 1988) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 9.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal status and estrogen-receptor (ER) status and randomized to receive either 12 cycles of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or CMFP plus tamoxifen (CMFPT), or observation alone." | 9.05 | Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. ( Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC, 1985) |
| "To assess whether low doses of prednisone produce generalized alterations in skeletal homeostasis in rheumatoid arthritis (RA), indices of calcium metabolism and bone mineral density (BMD) were measured in 22 women with RA treated without or with prednisone (6." | 7.68 | Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. ( el-Hajj Fuleihan, G; Leboff, MS; Liang, MH; Mackowiak, S; Wade, JP; Zangari, M, 1991) |
| "Prednisone-induced osteoporosis is very frequent in the long-term treatment of sarcoidosis (sarcoidosis 4:45-48, 1987)." | 7.67 | Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. ( Montemurro, L; Rizzato, G; Schiraldi, G; Sisti, S; Tosi, G; Zanni, D, 1988) |
| "This study summarizes the treatment effect of zoledronic acid infusion on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis." | 5.16 | Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. ( Bucci-Rechtweg, C; Devogelaer, JP; Lau, CS; Papanastasiou, P; Reginster, JY; Reid, DM; Roux, C; Saag, K; Sambrook, PN; Su, G, 2012) |
| "Three hundred ten patients with Stage II or Stage III breast cancer were entered on an adjuvant protocol consisting of a combination of 5-fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone (FACVP)." | 5.06 | Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. ( Ames, FC; Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, S; Marcus, C; Martin, RG; Smith, TL, 1988) |
| "Following mastectomy for node-positive breast cancer, 261 postmenopausal women were randomized to observation or adjuvant treatment with cyclophosphamide, fluorouracil, prednisone (CFP) alone or combined with tamoxifen (T)." | 5.06 | Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; Martin, JK; Paulsen, JK; Twito, DI; Votava, HJ; Wieand, HS; Wold, LE, 1988) |
| "Postmenopausal women who underwent modified radical mastectomy for Stage II, estrogen receptor (ER)-positive breast cancer were randomized to receive endocrine treatment (tamoxifen [T], 40 mg daily for 3 years) alone versus endocrine treatment plus five-drug chemotherapy (Cytoxan [cyclophosphamide, C], methotrexate [M], 5-fluorouracil [F], vincristine [V], and prednisone [P], CMFVP, for 1 year)." | 5.06 | Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer. ( Arafah, BM; Crowe, JP; Gordon, NH; Hubay, CA; Marshall, JS; McGuire, W; Pearson, OH, 1989) |
| "The Eastern Cooperative Oncology Group (ECOG) trial of adjuvant cyclophosphamide, methotrexate, fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen (CMFPT) for 1 year compared with observation alone in 265 postmenopausal patients with node-positive breast cancer is reported with 74 months median follow-up." | 5.06 | Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. ( Carbone, PP; Cummings, FJ; Falkson, G; Gilchrist, KW; Knuiman, MW; Olson, JE; Rosenthal, SN; Sleeper, LA; Taylor, SG; Tormey, DC, 1989) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 5.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "Eight hundred eighteen premenopausal or perimenopausal breast cancer patients with axillary node metastases were treated with adjuvant chemotherapy (CMF) with or without endocrine treatment (prednisone, oophorectomy) in two concurrent prospective trials." | 5.06 | Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. ( Castiglione, M; Gelber, RD; Goldhirsch, A, 1988) |
| "We have analyzed the relationship between dose intensity of cyclophosphamide, methotrexate, and fluorouracil (CMF)-containing adjuvant chemotherapy of stage II breast cancer and 3-year relapse-free survival." | 5.06 | Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. ( Hryniuk, W; Levine, MN, 1986) |
| "Between 1978 and 1981, 463 evaluable postmenopausal patients 65 years of age or younger with operable breast cancer and metastases in axillary lymph nodes were entered in Ludwig Breast Cancer Study III (Ludwig III) and randomly allocated to receive chemoendocrine therapy with cyclophosphamide, methotrexate, 5-fluorouracil, low-dose continuous prednisone, and tamoxifen (CMFp + T) for 12 monthly cycles, or endocrine therapy alone with prednisone and tamoxifen (p + T) for 1 year, or no adjuvant treatment after mastectomy (observation)." | 5.06 | A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. ( Gelber, RD; Goldhirsch, A, 1986) |
| "Adjuvant therapy after total mastectomy and axillary clearance in postmenopausal women with breast cancer and axillary node metastasis was assessed; chemo-endocrine therapy (cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen; CMFp + T) was compared with endocrine therapy (prednisone and tamoxifen; p + T), and with no adjuvant treatment in 463 patients aged less than or equal to 65 years." | 5.05 | Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis. ( , 1984) |
| "The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone) to two years of intermittent L-phenylalanine mustard (L-PAM) in women with operable breast cancer with histologically positive axillary lymph nodes." | 5.05 | Adjuvant therapy of breast cancer: the Southwest Oncology Group experience. ( Athens, JW; Costanzi, JJ; Foulkes, MA; Glucksberg, H; Knight, WA; O'Bryan, RM; Rivkin, SE; Stephens, RL, 1983) |
| "We report the results of a randomized trial carried out by the Swiss Group for Clinical Cancer Research (SAKK) and in which 230 patients with advanced breast cancer receiving concurrently a hormonal treatment (oophorectomy for pre- and tamoxifen for postmenopausal women) were randomly allocated to three different regimens of combination chemotherapy." | 5.05 | Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer. ( Alberto, P; Brunner, KW; Cavalli, F; Goldhirsch, A; Jungi, WF; Martz, G; Mermillod, B; Pedrazzini, A, 1983) |
| "After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal status and estrogen-receptor (ER) status and randomized to receive either 12 cycles of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or CMFP plus tamoxifen (CMFPT), or observation alone." | 5.05 | Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. ( Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC, 1985) |
| "The management of primary breast carcinoma has undergone a successful change during the decade of the 1970s." | 3.75 | Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas. ( DeVita, VT; Henney, JE; Weiss, RB, 1981) |
| " Fifty-six per cent of patients met osteoporotic criteria; a greater proportion of patients treated with prednisone had osteoporosis compared with those an hydrocortisone." | 3.72 | Long-term follow-up of bone mineral density in Addison's disease. ( Hawkins, F; Jara, A; Jódar, E; Martinez, G; Valdepeñas, MP, 2003) |
| "To assess whether low doses of prednisone produce generalized alterations in skeletal homeostasis in rheumatoid arthritis (RA), indices of calcium metabolism and bone mineral density (BMD) were measured in 22 women with RA treated without or with prednisone (6." | 3.68 | Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. ( el-Hajj Fuleihan, G; Leboff, MS; Liang, MH; Mackowiak, S; Wade, JP; Zangari, M, 1991) |
| "To investigate the effect of low doses of 2 different glucocorticoids on bone mass, sex hormone status and bone metabolic indices, a study was undertaken in 16 postmenopausal women with rheumatoid arthritis (RA) receiving < 15 mg/day of deflazacort and in 16 patients with RA matched for age, years postmenopause and disease duration, receiving < 10 mg/day of prednisone." | 3.68 | Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids. ( Caporali, R; Caprotti, M; Caprotti, P; Montecucco, C; Notario, A, 1992) |
| "Prednisone-induced osteoporosis is very frequent in the long-term treatment of sarcoidosis (sarcoidosis 4:45-48, 1987)." | 3.67 | Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. ( Montemurro, L; Rizzato, G; Schiraldi, G; Sisti, S; Tosi, G; Zanni, D, 1988) |
| "A series of 41 patients at the MGH who received 5-drug chemotherapy, cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisone, (CMF VP) as adjuvant to surgical treatment of operable breast cancer with 4 or more positive axillary nodes is compared to an analogous group of patients treated with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) reported by Bonadonna et al." | 3.66 | 5-drug adjuvant chemotherapy for breast cancer. ( Carey, RW; Halpern, E; Kaufman, S; Kelley, RM; Lew, RA; Sohier, WD; Weitzman, SA, 1979) |
| "Twenty-five patients with advanced metastatic breast cancer were treated with the combination of methotrexate 60 mg/M(2) and 5-fluorouracil 700 mg/M(2) intravenously on the first and eighth days, and cyclophosphamide 100 mg/M(2) and prednisone 40 mg/M(2) by mouth daily for the first 14 days of a 28-day cycle." | 3.65 | Cyclical combination chemotherapy for advanced breast carcinoma. ( Canellos, GP; Chabner, BA; Devita, VT; Gold, GL; Schein, PS; Young, RC, 1974) |
| "Postoperative women with breast cancer but without histopathological evidence of metastases to the axillary lymph nodes or clinical evidence of metastases were studied." | 2.67 | Chemotherapy versus observation in high-risk node-negative breast cancer patients. ( Cooper, MR; Eudey, L; Falkson, G; Gilchrist, KW; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC, 1992) |
| "Treatment results are available (Ludwig Breast Cancer Study Group, Lancet i (1984) 1256-1260)." | 2.66 | Adjuvant treatment in operable breast cancer. ( Goldhirsch, A, 1985) |
| " They were then assigned at random to receive no further therapy, ovarian irradiation (2000 rad in five days) or ovarian irradiation in the same dosage plus prednisone, 7." | 2.65 | Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Jenkin, RD; Meakin, JW; Pringle, JF; Reid, JG, 1983) |
| "Adjuvant therapy trials in breast cancer have grown steadily more complex since 1971, when the first long-term adjuvant trial in the United States was initiated." | 2.65 | Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience. ( Carbone, PP, 1983) |
| " They were then assigned at random to receive no further therapy, ovarian irradiation (2000 rads in 5 days) or ovarian irradiation in the same dosage plus prednisone, 7." | 2.65 | Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Brown, TC; Bulbrook, RD; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Hayward, JL; Jenkin, RD; Meakin, JW; Pringle, JF; Reid, JG; Rider, WD, 1979) |
| "Since in the treatment of advanced breast cancer chemotherapy and the various hormonal manipulations seem recently to have reached a plateau of effectiveness when used alone, it is widely assumed that the combination of both treatment modalities could improve therapeutic results." | 2.65 | [Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer]. ( Alberto, P; Beer, M; Brunner, KW; Cavalli, F; Jungi, WF; Martz, G; Mermillod, B; Obrecht, JP, 1982) |
| "Although no breast cancer patient can be cured after metastases have been found, the fact that survival is prolonged and the symptoms and signs of advanced disease can be relieved, often impressively, by the administration of cytostatic chemotherapy justifies their implementation." | 1.27 | [Cytostatic therapy in metastatic breast cancer]. ( Lenzhofer, R; Rainer, H, 1984) |
| " While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance." | 1.26 | [Results of, and indications for adjuvant chemotherapy in breast cancer]. ( Brunner, KW; Goldhirsch, A; Joss, R; Sonntag, RW; Tschopp, L, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 77 (79.38) | 18.7374 |
| 1990's | 14 (14.43) | 18.2507 |
| 2000's | 3 (3.09) | 29.6817 |
| 2010's | 3 (3.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Munno, O | 1 |
| Delle Sedie, A | 1 |
| Roux, C | 1 |
| Reid, DM | 1 |
| Devogelaer, JP | 1 |
| Saag, K | 1 |
| Lau, CS | 1 |
| Reginster, JY | 1 |
| Papanastasiou, P | 1 |
| Bucci-Rechtweg, C | 1 |
| Su, G | 1 |
| Sambrook, PN | 1 |
| Behringer, K | 1 |
| Thielen, I | 1 |
| Mueller, H | 1 |
| Goergen, H | 1 |
| Eibl, AD | 1 |
| Rosenbrock, J | 1 |
| Halbsguth, T | 1 |
| Eichenauer, DA | 1 |
| Fuchs, M | 1 |
| Reiners, KS | 1 |
| Renno, JH | 1 |
| van der Ven, K | 1 |
| Kuehr, M | 1 |
| von Wolff, M | 1 |
| Diehl, V | 1 |
| Engert, A | 1 |
| Borchmann, P | 1 |
| Rivkin, SE | 4 |
| Green, SJ | 2 |
| Lew, D | 1 |
| Costanzi, JJ | 2 |
| Athens, JW | 2 |
| Osborne, CK | 3 |
| Vaughn, CB | 1 |
| Martino, S | 1 |
| Jódar, E | 1 |
| Valdepeñas, MP | 1 |
| Martinez, G | 1 |
| Jara, A | 1 |
| Hawkins, F | 1 |
| HEATHER, AJ | 1 |
| LEMON, HM | 1 |
| PARSONS, L | 1 |
| MOZDEN, PH | 1 |
| NISSEN-MEYER, R | 2 |
| ZEFIROVA, GS | 1 |
| HINTERBUCHNER, CN | 1 |
| HINTERBUCHNER, LP | 1 |
| Sanner, T | 1 |
| Carbone, PP | 4 |
| Wood, WC | 1 |
| Knight, WA | 1 |
| Glucksberg, H | 3 |
| Foulkes, MA | 1 |
| Stephens, RL | 1 |
| O'Bryan, RM | 1 |
| Meakin, JW | 5 |
| Allt, WE | 4 |
| Beale, FA | 4 |
| Bush, RS | 4 |
| Clark, RM | 4 |
| Fitzpatrick, PJ | 4 |
| Hawkins, NV | 4 |
| Jenkin, RD | 4 |
| Pringle, JF | 4 |
| Reid, JG | 4 |
| Handelsman, DJ | 1 |
| McDowell, IF | 1 |
| Caterson, ID | 1 |
| Tiller, DJ | 1 |
| Hall, BM | 1 |
| Turtle, JR | 1 |
| Hubay, CA | 2 |
| Arafah, B | 1 |
| Gordon, NH | 2 |
| Guyton, SP | 1 |
| Crowe, JP | 2 |
| Gelber, RD | 5 |
| Tormey, C | 1 |
| Foulkes, M | 1 |
| Rossi, A | 3 |
| Brambilla, C | 3 |
| Valagussa, P | 4 |
| Bonadonna, G | 4 |
| Rainer, H | 1 |
| Lenzhofer, R | 1 |
| Goldhirsch, A | 9 |
| Cavalli, F | 3 |
| Pedrazzini, A | 1 |
| Martz, G | 3 |
| Jungi, WF | 2 |
| Brunner, KW | 5 |
| Mermillod, B | 2 |
| Alberto, P | 3 |
| Hirshaut, Y | 1 |
| Kesselheim, H | 1 |
| Weiss, RB | 1 |
| Henney, JE | 1 |
| DeVita, VT | 2 |
| Rider, WD | 3 |
| Hayward, JL | 2 |
| Bulbrook, RD | 2 |
| Tranum, BL | 1 |
| McDonald, B | 1 |
| Thigpen, T | 1 |
| Vaughn, C | 2 |
| Wilson, H | 1 |
| Maloney, T | 2 |
| Costanzi, J | 2 |
| Bickers, J | 1 |
| el Mawli, NG | 1 |
| Palmer, R | 1 |
| Hoogstraten, B | 2 |
| Heilburn, L | 1 |
| Rasmusen, S | 1 |
| Rasmussen, S | 1 |
| Tranum, B | 1 |
| Gad-el-Mawla, N | 1 |
| Athens, J | 1 |
| McCracken, J | 1 |
| Beer, M | 1 |
| Obrecht, JP | 1 |
| Nemoto, T | 1 |
| Horton, J | 1 |
| Simon, R | 1 |
| Dao, TL | 1 |
| Rosner, D | 1 |
| Cunningham, T | 1 |
| Sponzo, R | 1 |
| Snyderman, M | 1 |
| Joss, R | 2 |
| Sonntag, RW | 2 |
| Tschopp, L | 1 |
| Bhardwaj, S | 1 |
| Holland, JF | 2 |
| Norton, L | 1 |
| Canavese, JC | 1 |
| Senn, HJ | 1 |
| Obrecht, P | 1 |
| Maurice, P | 1 |
| Brown, TC | 1 |
| Garza-Chapa, R | 1 |
| Alvarez-de Santos, M | 1 |
| Marroquín, MA | 1 |
| Gutiérrez, O | 1 |
| Carey, RW | 1 |
| Sohier, WD | 1 |
| Kaufman, S | 1 |
| Weitzman, SA | 1 |
| Kelley, RM | 1 |
| Lew, RA | 1 |
| Halpern, E | 1 |
| Marshall, DH | 1 |
| Crilly, R | 1 |
| Nordin, BE | 1 |
| Lozada, JA | 1 |
| Grillo-López, A | 1 |
| Vélez-Garciá, E | 1 |
| Montecucco, C | 1 |
| Caporali, R | 1 |
| Caprotti, P | 1 |
| Caprotti, M | 1 |
| Notario, A | 1 |
| Messina, OD | 1 |
| Barreira, JC | 1 |
| Zanchetta, JR | 1 |
| Maldonado-Cocco, JA | 1 |
| Bogado, CE | 1 |
| Sebastián, ON | 1 |
| Flores, D | 1 |
| Riopedre, AM | 1 |
| Redondo, G | 1 |
| Lázaro, A | 1 |
| Mansour, EG | 2 |
| Eudey, L | 1 |
| Tormey, DC | 6 |
| Shatila, AH | 2 |
| Gilchrist, KW | 3 |
| Cooper, MR | 2 |
| Falkson, G | 6 |
| Laan, RF | 1 |
| van Riel, PL | 1 |
| van Erning, LJ | 1 |
| Lemmens, JA | 1 |
| Ruijs, SH | 1 |
| van de Putte, LB | 1 |
| Luboinski, G | 1 |
| Nagadowska, M | 1 |
| Pienkowski, T | 1 |
| Leboff, MS | 1 |
| Wade, JP | 1 |
| Mackowiak, S | 1 |
| el-Hajj Fuleihan, G | 1 |
| Zangari, M | 1 |
| Liang, MH | 1 |
| Hartmann, LC | 1 |
| Marschke, RF | 2 |
| Schaid, DJ | 1 |
| Ingle, JN | 4 |
| Felder, M | 1 |
| Rüegsegger, P | 1 |
| Castiglione, M | 2 |
| Falkson, HC | 1 |
| Gray, R | 3 |
| Wolberg, WH | 1 |
| Gillchrist, KW | 1 |
| Harris, JE | 1 |
| Camoriano, JK | 1 |
| Loprinzi, CL | 1 |
| Therneau, TM | 1 |
| Krook, JE | 3 |
| Veeder, MH | 1 |
| LoCascio, V | 1 |
| Bonucci, E | 1 |
| Imbimbo, B | 1 |
| Ballanti, P | 1 |
| Adami, S | 1 |
| Milani, S | 1 |
| Tartarotti, D | 1 |
| DellaRocca, C | 1 |
| Gilchrist, K | 1 |
| Grage, T | 1 |
| Wolter, J | 1 |
| Woll, JE | 1 |
| Cummings, FJ | 2 |
| Mouridsen, HT | 1 |
| Taylor, SG | 2 |
| Knuiman, MW | 1 |
| Sleeper, LA | 1 |
| Olson, JE | 2 |
| Rosenthal, SN | 1 |
| Stewart, HJ | 1 |
| Pearson, OH | 1 |
| Marshall, JS | 1 |
| Arafah, BM | 1 |
| McGuire, W | 1 |
| Wang, KK | 1 |
| Czaja, AJ | 1 |
| Everson, LK | 2 |
| Wieand, HS | 1 |
| Martin, JK | 1 |
| Votava, HJ | 1 |
| Wold, LE | 1 |
| Cullinan, SA | 2 |
| Paulsen, JK | 1 |
| Twito, DI | 1 |
| Buzdar, AU | 1 |
| Hortobagyi, GN | 1 |
| Smith, TL | 1 |
| Kau, S | 1 |
| Marcus, C | 1 |
| Holmes, FA | 1 |
| Hug, V | 1 |
| Fraschini, G | 1 |
| Ames, FC | 1 |
| Martin, RG | 1 |
| Rizzato, G | 2 |
| Tosi, G | 2 |
| Mella, C | 1 |
| Montemurro, L | 2 |
| Zanni, D | 2 |
| Sisti, S | 2 |
| Schiraldi, G | 1 |
| Hryniuk, W | 1 |
| Levine, MN | 1 |
| Swain, SM | 1 |
| Lippman, ME | 1 |
| Le Pors, P | 1 |
| Tschupp, MJ | 1 |
| de Queiroz, D | 1 |
| Grosbois, B | 1 |
| Lemoine, H | 1 |
| Grall, JY | 1 |
| Gelman, RS | 1 |
| Pretorius, FJ | 1 |
| Dnistrian, AM | 1 |
| Greenberg, EJ | 1 |
| Dillon, HJ | 1 |
| Hakes, TB | 1 |
| Fracchia, AA | 1 |
| Schwartz, MK | 1 |
| Tancini, G | 1 |
| Zambetti, M | 1 |
| Veronesi, U | 1 |
| Sertoli, MR | 1 |
| Scarsi, PG | 1 |
| Rosso, R | 1 |
| Lebovics, E | 1 |
| Schaffner, F | 1 |
| Klion, FM | 1 |
| Simon, C | 1 |
| Carter, SK | 1 |
| Henderson, IC | 1 |
| Kalish, LA | 1 |
| Cummings, F | 1 |
| Bennett, JM | 1 |
| Bowman, WD | 1 |
| Windschitl, HE | 1 |
| Laurie, JA | 1 |
| Pfeifle, DM | 1 |
| Hangartner, TN | 1 |
| Overton, TR | 1 |
| Harley, CH | 1 |
| van den Berg, L | 1 |
| Crockford, PM | 1 |
| Gardner, B | 1 |
| Kerr, WS | 1 |
| Thompson, RG | 1 |
| Rodriguez, A | 1 |
| Kowarski, A | 1 |
| Blizzard, RM | 1 |
| Lee, JM | 1 |
| Abeloff, MD | 1 |
| Lenhard, RE | 1 |
| Baker, RR | 1 |
| Canellos, GP | 1 |
| Gold, GL | 1 |
| Chabner, BA | 1 |
| Schein, PS | 1 |
| Young, RC | 1 |
| Jurist, JM | 1 |
| Nilius, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment: a Prospective Cohort Study on Patients Affected by Breast Cancer[NCT03210441] | 204 participants (Anticipated) | Observational | 2014-05-06 | Recruiting | |||
| Adjuvant Dose-dense Sequential Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study[NCT04829890] | 89 participants (Actual) | Observational | 2004-02-29 | Completed | |||
| Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial[NCT00001250] | Phase 2 | 130 participants | Interventional | 1989-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for prednisone and Menopause
| Article | Year |
|---|---|
[Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios].
Topics: Adult; Aged; Algorithms; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fra | 2011 |
Hormone receptors. An update and application.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Combined Modality The | 1984 |
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrog | 1981 |
[Lupus erythematosus, modern aspects (author's transl)].
Topics: Antacids; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Chlorambucil; Cyclophosph | 1977 |
Controversies in the treatment of cancer of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1987 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 1985 |
Hormono-chemotherapy in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
48 trials available for prednisone and Menopause
| Article | Year |
|---|---|
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bone Density; Bone De | 2012 |
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Axil | 2003 |
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Adjuvant therapy of breast cancer: the Southwest Oncology Group experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; | 1983 |
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trial | 1984 |
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1984 |
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Chlorambucil; Combined | 1983 |
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrog | 1981 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Ova | 1980 |
Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Dr | 1982 |
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Flu | 1982 |
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as T | 1982 |
Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Th | 1982 |
An intensive sequenced adjuvant chemotherapy regimen for breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Com | 1993 |
Combined chemo- and hormonal therapy in advanced breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as Topic; Cycloph | 1977 |
Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Follow-Up Studies; Hum | 1979 |
Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Dose-Response | 1992 |
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Com | 1992 |
Systemic adjuvant therapy in women with resected node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1991 |
Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Evaluation | 1990 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administrat | 1990 |
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality The | 1990 |
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1990 |
How to improve adjuvant treatment results in postmenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; | 1989 |
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclopho | 1989 |
Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1989 |
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined | 1989 |
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; C | 1989 |
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1989 |
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1988 |
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1988 |
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1988 |
Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclopho | 1986 |
Age as a prognostic factor in recurrent breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined | 1986 |
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; C | 1986 |
Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1985 |
Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Tr | 1985 |
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 1985 |
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
Hormono-chemotherapy in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
Adjuvant treatment in operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cy | 1985 |
45 other studies available for prednisone and Menopause
| Article | Year |
|---|---|
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosp | 2012 |
Long-term follow-up of bone mineral density in Addison's disease.
Topics: Addison Disease; Aged; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Bone Density; Fem | 2003 |
TREATMENT OF OSTEOPOROSIS WITH AN ANABOLIC COMPOUND AND L-LYSINE.
Topics: Amino Acids; Anabolic Agents; Appetite; Arthritis; Arthritis, Rheumatoid; Dietary Proteins; Emotions | 1963 |
ABDOMINOVAGINAL POTENTIAL DIFFERENCE IN POSTMENOPAUSAL PATIENTS WITH AND WITHOUT BREAST CANCER.
Topics: Abdominal Wall; Adolescent; Androgens; Breast Neoplasms; Castration; Climacteric; Electrophysiology; | 1964 |
PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST.
Topics: Androgens; Breast Neoplasms; Castration; Cortisone; Estrogens; Female; Humans; Mastectomy; Menopause | 1964 |
ENDOCRINE TREATMENT OF BREAST CANCER.
Topics: Anabolic Agents; Androgens; Breast Neoplasms; Castration; Estrone; Female; Humans; Menopause; Nandro | 1964 |
[ADDISON'S DISEASE ASSOCIATED WITH ARTERIAL HYPERTENSION].
Topics: Addison Disease; Adrenal Insufficiency; Ascorbic Acid; Cortisone; Desoxycorticosterone; Dexamethason | 1964 |
MYOPATHIC SYNDROME IN MUSCULAR SARCOIDOSIS.
Topics: Biopsy; Black People; Bone Marrow Examination; Electromyography; Female; Humans; Menopause; Muscles; | 1964 |
Determination of urinary pregnanediol. A comparison between chemical and gas chromatographic methods.
Topics: Adrenal Glands; Chromatography, Gas; Female; Humans; Male; Menopause; Middle Aged; Prednisone; Pregn | 1967 |
Ovarian function after renal transplantation: comparison of cyclosporin A with azathioprine and prednisone combination regimens.
Topics: Adult; Azathioprine; Cyclosporins; Drug Therapy, Combination; Female; Humans; Kidney Transplantation | 1984 |
[Cytostatic therapy in metastatic breast cancer].
Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 1984 |
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modalit | 1984 |
Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast | 1983 |
[Results of, and indications for adjuvant chemotherapy in breast cancer].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; | 1981 |
Is there a place for adjuvant endocrine therapy of breast cancer?
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Castration; Drug Therapy, Combination; Female; Human | 1980 |
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2001 |
[Effect of hormonal factors on the frequency of sex chromatin].
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Aged; Child; Child, Preschool; Female; Humans; I | 1977 |
5-drug adjuvant chemotherapy for breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluoro | 1979 |
The relation between plasma androstenedione and oestrone levels in untreated and corticosteroid-treated post-menopausal women.
Topics: Adrenal Cortex Hormones; Adult; Aged; Androstenedione; Castration; Estrone; Female; Humans; Menopaus | 1978 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Ovary; Predni | 1978 |
Therapy of primary breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Lymphatic Metasta | 1977 |
Combination chemotherapy for disseminated carcinoma of the breast.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Com | 1975 |
Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bo | 1992 |
Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.
Topics: Arthritis, Rheumatoid; Bone Density; Dose-Response Relationship, Drug; Female; Humans; Male; Menopau | 1992 |
Preoperative chemotherapy in primarily inoperable cancer of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1991 |
Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Bone Density; Calcium; Dose-Response Relationship, Drug; Female; | 1991 |
Bone loss in patients with rheumatoid arthritis--effect of steroids measured by low dose quantitative computed tomography.
Topics: Adult; Aged; Arthritis, Rheumatoid; Bone Density; Female; Humans; Menopause; Middle Aged; Osteoporos | 1991 |
Bone loss in response to long-term glucocorticoid therapy.
Topics: Adult; Aged; Bone Diseases, Metabolic; Drug Therapy, Combination; Female; Humans; Longitudinal Studi | 1990 |
Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Hepatitis B Surface Antigens; Hepatitis, Chr | 1989 |
Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women.
Topics: Adult; Aged; Female; Humans; Lumbar Vertebrae; Male; Menopause; Middle Aged; Minerals; Osteoporosis; | 1988 |
Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.
Topics: Adult; Calcitonin; Chronic Disease; Female; Humans; Male; Menopause; Middle Aged; Minerals; Osteopor | 1988 |
[Twin pregnancy after iatrogenic menopause].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Estrogens; Female; Hodgkin Disease; Humans; I | 1987 |
Case 6-1985: progressive pneumonitis after chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1985 |
Chemohormonal therapy and endocrine function in breast cancer patients.
Topics: Adult; Amenorrhea; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cycl | 1985 |
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neopla | 1985 |
Rationale for combining chemotherapy and hormonal therapy in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosph | 1985 |
Autoimmune chronic active hepatitis in postmenopausal women.
Topics: Aged; Antibodies, Antinuclear; Ascites; Autoimmune Diseases; Azathioprine; Diabetes Mellitus; Drug T | 1985 |
Skeletal challenge: an experimental study of pharmacologically induced changes in bone density in the distal radius, using gamma-ray computed tomography.
Topics: Aged; Bone and Bones; Calcitriol; Calcium; Densitometry; Ergocalciferols; Female; Gamma Rays; Humans | 1985 |
Current concepts in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Adult; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Fluorouracil; Huma | 1972 |
Interstitial cystitis: treatment by transurethral resection.
Topics: Cystitis; Cystoscopy; Dimethyl Sulfoxide; Female; Heparin; Histamine H1 Antagonists; Humans; Menopau | 1971 |
Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone.
Topics: Acromegaly; Adult; Aged; Circadian Rhythm; Contraceptive Agents; Depression, Chemical; Female; Growt | 1972 |
An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Breast Neoplasms; Cyclophosphamide; Drug Therap | 1974 |
Cyclical combination chemotherapy for advanced breast carcinoma.
Topics: Adrenalectomy; Adult; Alopecia; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Castration; Cyclophos | 1974 |
Effect of corticosteroids on ulnar resonant frequency.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Biomechanical Phenomena; Bone and Bones; Female; Hum | 1971 |
[Bone changes due to prednisone addiction].
Topics: Diagnosis, Differential; Female; Fractures, Spontaneous; Gastric Juice; Humans; Kidney Function Test | 1965 |